Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
上皮细胞NOTCH信号通路重塑结直肠癌肿瘤微环境,从而驱动预后不良亚型和转移
阅读:3
作者:Rene Jackstadt ,Sander R van Hooff ,Joshua D Leach ,Xabier Cortes-Lavaud ,Jeroen O Lohuis ,Rachel A Ridgway ,Valérie M Wouters ,Jatin Roper ,Timothy J Kendall ,Campbell S Roxburgh ,Paul G Horgan ,Colin Nixon ,Craig Nourse ,Matthias Gunzer ,William Clark ,Ann Hedley ,Omer H Yilmaz ,Mamunur Rashid ,Peter Bailey ,Andrew V Biankin ,Andrew D Campbell ,David J Adams ,Simon T Barry ,Colin W Steele ,Jan Paul Medema ,Owen J Sansom
| 期刊: | Cancer Cell | 影响因子: | 48.800 |
| 时间: | 2019 | 起止号: | 2019 Sep 16;36(3):319-336. |
| doi: | 10.1016/j.ccell.2019.08.003 | 研究方向: | 信号转导、肿瘤 |
| 疾病类型: | 肠癌 | 信号通路: | Notch |
Abstract
The metastatic process of colorectal cancer (CRC) is not fully understood and effective therapies are lacking. We show that activation of NOTCH1 signaling in the murine intestinal epithelium leads to highly penetrant metastasis (100% metastasis; with >80% liver metastases) in KrasG12D-driven serrated cancer. Transcriptional profiling reveals that epithelial NOTCH1 signaling creates a tumor microenvironment (TME) reminiscent of poorly prognostic human CRC subtypes (CMS4 and CRIS-B), and drives metastasis through transforming growth factor (TGF) β-dependent neutrophil recruitment. Importantly, inhibition of this recruitment with clinically relevant therapeutic agents blocks metastasis. We propose that NOTCH1 signaling is key to CRC progression and should be exploited clinically.
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。